Riverview Trust Co和投资者调整了AbbVie的股权, Riverview Trust Co and investors adjust stakes in AbbVie, despite strong earnings and a "Moderate Buy" rating.

Riveview Trust Co和其他机构投资者调整了他们在AbbVie Inc的股权,有些出售股票,有些增加股份。 Riverview Trust Co and other institutional investors have adjusted their stakes in AbbVie Inc., with some selling off shares and others increasing their holdings. AbbVie的股票价值为3 308.2亿美元,该公司报告收入丰厚,估计有2.46 EPS。 AbbVie's stock is valued at $330.82 billion, and the company reported strong earnings, beating estimates with $2.46 EPS. 股价为212.19美元的目标价位。 The stock has a "Moderate Buy" rating with a target price of $212.19. EVP Jeffrey Ryan Stewart也出售了58,832股股份,将所有权减少了52.50%。 EVP Jeffrey Ryan Stewart also sold 58,832 shares, reducing his ownership by 52.50%.